Patents by Inventor Lisa M. Fitzgerald

Lisa M. Fitzgerald has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160262853
    Abstract: A temporary, flow-through oral shield system to protect an oral surgical area during a healing process includes a molded body forming a first channel extending from a distal end of the molded body to a proximal end of the molded body and an aperture formed in the molded body in fluid communication with the first channel.
    Type: Application
    Filed: November 13, 2015
    Publication date: September 15, 2016
    Inventors: Cherie Le Penske, Lisa M. Fitzgerald, Gregg Hallam, Katherine A. Haltom, Gaetano P. LaTorre
  • Patent number: 8365665
    Abstract: A fireworks igniter system and method for safely igniting fuse-type fireworks including a handheld igniter module and a remote control module. An igniter head at the proximal end of the igniter module includes a heater element and fuse clamp slide which receives and biasingly molds the fuse against the heater element. A microprocessor in the igniter module includes an infrared receiver and an igniter module actuator. The remote control module includes an infrared emitter and a remote control module actuator, the infrared emitter emitting a coded IR signal in response to activation of the actuator. The IR signal is sensed by the infrared receiver to activate the igniter module actuator and deliver electric current to the heater element sufficient to ignite the fuse.
    Type: Grant
    Filed: April 11, 2011
    Date of Patent: February 5, 2013
    Inventors: Andrew Risner, Lisa M. Fitzgerald
  • Publication number: 20120255455
    Abstract: A fireworks igniter system and method for safely igniting fuse-type fireworks including a handheld igniter module and a remote control module. An igniter head at the proximal end of the igniter module includes a heater element and fuse clamp slide which receives and biasingly molds the fuse against the heater element. A microprocessor in the igniter module includes an infrared receiver and an igniter module actuator. The remote control module includes an infrared emitter and a remote control module actuator, the infrared emitter emitting a coded IR signal in response to activation of the actuator. The IR signal is sensed by the infrared receiver to activate the igniter module actuator and deliver electric current to the heater element sufficient to ignite the fuse.
    Type: Application
    Filed: April 11, 2011
    Publication date: October 11, 2012
    Inventors: Andrew Risner, Lisa M. Fitzgerald
  • Patent number: 8186308
    Abstract: A pet washing restraint including hollow support member, preferably having a pyramid-like shape and also having a base end and a distal end, the support member tapering from the base end. Spaced apart suction members are connected to, and face away from, the base end and are adapted for releasable attachment to an upright wall surface of a bathing tub. A pet torso-engaging strap is attached to, and extends from the distal end for engagement around a torso of the pet. The support member is sized in length to position and restrain the pet held within the strap encircling the torso of the pet from substantial movement centrally within the bathing tub. A second restraint acting together in side-by-side fashion may also be provided for enhanced pet movement control.
    Type: Grant
    Filed: April 23, 2010
    Date of Patent: May 29, 2012
    Assignee: Pet Wash Inc.
    Inventors: Juraj Hluben, Russell G. Moore, Lisa M. Fitzgerald
  • Patent number: 7850536
    Abstract: A putting training device for improving consistency of body position, putter path, putter face angle, and timing during a putting stroke. A body alignment target within a putter data module helps position the golfer's head directly over the ball for shoulder joint consistently relative to the ball. A magnet is securable to the C.G. of the putter head which is tracked by sensors within the module to help insure that the putter travels in a straight line on approach to ball strike. Optical sensors determine the putter face angle at ball impact. A metronome is also provided to practice swing timing. An end-of-swing delay indicator helps to hold the golfer's body in the correct position until the follow-through is complete. A series of lights and tones provides feedback indicating putter path to the ball and the putter face angle at ball impact.
    Type: Grant
    Filed: January 29, 2010
    Date of Patent: December 14, 2010
    Assignee: Novatron Holdings Corporation
    Inventor: Lisa M. Fitzgerald
  • Patent number: 7727080
    Abstract: A golf swing analyzer providing a learning tool for golfers to help improve golf backswing and club face angle consistency. To gage the club angle relative to swing path, a fence is placed and held on the shaft perpendicular to the club face. During a golf swing, an air flow along this fence is created by the swinging motion of the club. For a perfect square shot, the pressures are equal on both sides of the fence; otherwise, as the fence angle changes relative to air flow, one side compacts the air, creating a high-pressure area while at the same time the opposite side dams the air flow and creates a low-pressure area. A differential pressure transducer detects this pressure difference on each side of the fence. When the ball is struck, a microphone in the device detects the ball impact and a microprocessor interprets the fence position relative to air flow based on the pressure transducer output.
    Type: Grant
    Filed: January 27, 2009
    Date of Patent: June 1, 2010
    Inventor: Lisa M. Fitzgerald
  • Publication number: 20080317754
    Abstract: Disclosed is a human osteoclast-derived cathepsin (Cathepsin O) polypeptide and DNA(RNA) encoding such cathepsin O polypeptides. Also provided is a procedure for producing such polypeptide by recombinant techniques. The present invention also discloses antibodies, antagonists and inhibitors of such polypeptide which may be used to prevent the action of such polypeptide and therefore may be used therapeutically to treat bone diseases such as osteoporosis and cancers, such as tumor metastases.
    Type: Application
    Filed: June 1, 2007
    Publication date: December 25, 2008
    Applicants: Human Genome Sciences, Inc., SmithKline Beecham Corp.
    Inventors: Gregg A. Hastings, Mark D. Adams, Claire M. Fraser, Norman H. Lee, Ewen F. Kirkness, Judith A. Blake, Lisa M. Fitzgerald, Fred H. Drake, Maxine Gowan
  • Patent number: 7291134
    Abstract: A needleless connector for adding medication to a parenteral fluid is provided. The needleless connector comprises a connector adapted to receive a syringe and having a check valve to seal the port in place of a puncture pad. The check valve comprises a resilient disc held in place and biased closed by the tensile stress of the check valve material. When a syringe or other apparatus having a male luer connector is engaged with the connector and fluid pressure is applied to the check valve the resilient disc is deformed which allows the medication to flow through the connector into the tubing and thus to the patient.
    Type: Grant
    Filed: October 25, 2004
    Date of Patent: November 6, 2007
    Assignee: P. Rowan Smith, Jr.
    Inventor: Lisa M. Fitzgerald
  • Patent number: 7288078
    Abstract: A spring loaded retractable needle syringe comprising a body, a central tube coaxially mounted within said body, a needle carrier and needle slidably mounted within said central tube, a spring mounted within said central tube to bias said needle carrier and needle into said central tube, means for sliding said needle carrier and needle within said central tube to compress said spring and expose said needle, means for retaining said needle carrier and needle in the exposed position against the biasing force of said spring, and means for releasing the needle carrier and needle such that said needle carrier and needle are retracted into said central tube.
    Type: Grant
    Filed: April 12, 2004
    Date of Patent: October 30, 2007
    Inventor: Lisa M. Fitzgerald
  • Patent number: 7270649
    Abstract: A catheter appliance having a catheter in fluid communication with a luer connector is releasably secured to a catheter applicator having a track for slidably mounting a needle carrier module. The needle carrier module includes a hypodermic which extends through the catheter for insertion and which is in fluid communication with a flashback indicator on the module. The catheter applicator includes a needle cavity for containing the hypodermic needle after use.
    Type: Grant
    Filed: July 14, 2004
    Date of Patent: September 18, 2007
    Inventor: Lisa M. Fitzgerald
  • Patent number: 7250039
    Abstract: A compression hypodermic syringe is disclosed wherein two leaves are hinged together. One leaf contains a receptacle for a collapsible capsule which contains a pre-measured dose of medication. The second leaf has a structure that acts as a plunger when the second leaf is folded over the first leaf. A double ended hypodermic needle is provided that has one end that pierces a membrane on the collapsible capsule and a second end that is exposed for insertion into a patient when the two leaves are folded together.
    Type: Grant
    Filed: July 15, 2004
    Date of Patent: July 31, 2007
    Inventor: Lisa M. Fitzgerald
  • Patent number: 7235371
    Abstract: Disclosed is a human osteoclast-derived cathepsin (Cathepsin O) polypeptide and DNA(RNA) encoding such cathepsin O polypeptides. Also provided is a procedure for producing such polypeptide by recombinant techniques. The present invention also discloses antibodies, antagonists and inhibitors of such polypeptide which may be used to prevent the action of such polypeptide and therefore may be used therapeutically to treat bone diseases such as osteoporosis and cancers, such as tumor metastases.
    Type: Grant
    Filed: July 21, 2005
    Date of Patent: June 26, 2007
    Assignees: Human Genome Sciences, Inc., SmithKline Beecham Corp.
    Inventors: Gregg A. Hastings, Mark D. Adams, Claire M. Fraser, Norman H. Lee, Ewen F. Kirkness, Judith A. Blake, Lisa M. Fitzgerald, Fred H. Drake, Maxine Gowan
  • Patent number: 6994978
    Abstract: Disclosed is a human osteoclast-derived cathepsin (Cathepsin O) polypeptide and DNA(RNA) encoding such cathepsin O polypeptides. Also provided is a procedure for producing such polypeptide by recombinant techniques. The present invention also discloses antibodies, antagonists and inhibitors of such polypeptide which may be used to prevent the action of such polypeptide and therefore may be used therapeutically to treat bone diseases such as osteoporosis and cancers, such as tumor metastases.
    Type: Grant
    Filed: December 4, 2003
    Date of Patent: February 7, 2006
    Assignees: Human Genome Sciences, Inc., SmithKline Beecham Corporation
    Inventors: Gregg A. Hastings, Mark D. Adams, Claire M. Fraser, Norman H. Lee, Ewen F. Kirkness, Judith A. Blake, Lisa M. Fitzgerald, Fred H. Drake, Maxine Gowan
  • Patent number: 6958054
    Abstract: A catheter device is disclosed which the hypodermic needle used for insertion is retracted into a protective sheath and left in place during use. An IV fluid flow path is provided that is blocked by the hypodermic needle prior to retraction but is opened by the retraction of the needle from the catheter. The insertion hypodermic needle is not discarded separately but only after the use of the whole catheter device to inject fluids.
    Type: Grant
    Filed: January 28, 2004
    Date of Patent: October 25, 2005
    Inventor: Lisa M. Fitzgerald
  • Patent number: 6680375
    Abstract: Disclosed is a human osteoclast-derived cathepsin (Cathepsin O) polypeptide and DNA(RNA) encoding such cathepsin O polypeptides. Also provided is a procedure for producing such polypeptide by recombinant techniques. The present invention also discloses antibodies, antagonists and inhibitors of such polypeptide which may be used to prevent the action of such polypeptide and therefore may be used therapeutically to treat bone diseases such as osteoporosis and cancers, such as tumor metastases.
    Type: Grant
    Filed: April 3, 2002
    Date of Patent: January 20, 2004
    Assignees: Human Genome Sciences, Inc., SmithKline Beecham Corporation
    Inventors: Gregg A. Hastings, Mark D. Adams, Claire M. Fraser, Norman H. Lee, Ewen F. Kirkness, Judith A. Blake, Lisa M. Fitzgerald, Fred H. Drake, Maxine Gowan
  • Publication number: 20030166863
    Abstract: The present invention relates to a human MIF-3 and DNA (RNA) encoding such polypeptide. Also provided is a procedure for producing such polypeptide by recombinant techniques and antibodies and antagonists against such polypeptide. Also provided are methods of using the polypeptide therapeutically for treating cancer, infections, acceleration of wound healing, stimulating the immune system, as an anti-inflammatory. Methods of using antibodies and antagonists for therapeutic purposes, is also disclosed, for example, for treating lethal endotoxaemia, ocular inflammation and diagnosing immune diseases. Also disclosed are diagnostic methods for detecting conditions related to a mutation in a nucleic acid sequence encoding a polypeptide of the present invention and altered levels of the polypeptide of the present invention.
    Type: Application
    Filed: June 25, 2002
    Publication date: September 4, 2003
    Applicant: Human Genome Sciences, Inc.
    Inventors: Haodong Li, Lisa M. Fitzgerald
  • Patent number: 6475766
    Abstract: Disclosed is a human osteoclast-derived cathepsin (Cathepsin O) polypeptide and DNA(RNA) encoding such cathepsin O polypeptides. Also provided is a procedure for producing such polypeptide by recombinant techniques. The present invention also discloses antibodies, antagonists and inhibitors of such polypeptide which may be used to prevent the action of such polypeptide and therefore may be used therapeutically to treat bone diseases such as osteoporosis and cancers, such as tumor metastases.
    Type: Grant
    Filed: November 7, 1995
    Date of Patent: November 5, 2002
    Assignees: Human Genome Sciences, Inc., SmithKline Beecham Corporation
    Inventors: Gregg A. Hastings, Mark D. Adams, Claire M. Fraser, Norman H. Lee, Ewen F. Kirkness, Judith A. Blake, Lisa M. Fitzgerald, Fred H. Drake, Maxine Gowan
  • Patent number: 6475487
    Abstract: Disclosed is a human osteoclast-derived cathepsin (Cathepsin O) polypeptide and DNA(RNA) encoding such cathepsin O polypeptides. Also provided is a procedure for producing such polypeptide by recombinant techniques. The present invention also discloses antibodies, antagonists and inhibitors of such polypeptide which may be used to prevent the action of such polypeptide and therefore may be used therapeutically to treat bone diseases such as osteoporosis and cancers, such as tumor metastases. A patient is treated by administering an antibody produced against a polypeptide consisting of SEQ ID NO: 2.
    Type: Grant
    Filed: September 18, 2001
    Date of Patent: November 5, 2002
    Assignees: Human Genome Sciences, Inc., SmithKline Beecham Corporation
    Inventors: Gregg A. Hastings, Mark D. Adams, Claire M. Fraser, Norman H. Lee, Ewen F. Kirkness, Judith A. Blake, Lisa M. Fitzgerald, Fred H Drake, Maxine Gowan
  • Publication number: 20020142448
    Abstract: Disclosed is a human osteoclast-derived cathepsin (Cathepsin O) polypeptide and DNA(RNA) encoding such cathepsin O polypeptides. Also provided is a procedure for producing such polypeptide by recombinant techniques. The present invention also discloses antibodies, antagonists and inhibitors of such polypeptide which may be used to prevent the action of such polypeptide and therefore may be used therapeutically to treat bone diseases such as osteoporosis and cancers, such as tumor metastases.
    Type: Application
    Filed: April 3, 2002
    Publication date: October 3, 2002
    Applicant: Human Genome Sciences, Inc.
    Inventors: Gregg A. Hastings, Mark D. Adams, Claire M. Fraser, Norman H. Lee, Ewen F. Kirkness, Judith A. Blake, Lisa M. Fitzgerald, Fred H. Drake, Maxine Gowan
  • Patent number: 6423507
    Abstract: Disclosed is a human osteoclast-derived cathepsin (Cathepsin O) polypeptide and DNA(RNA) encoding such cathepsin O polypeptides. Also provided is a procedure for producing such polypeptide by recombinant techniques. The present invention also discloses antibodies, antagonists and inhibitors of such polypeptide which may be used to prevent the action of such polypeptide and therefore may be used therapeutically to treat bone diseases such as osteoporosis and cancers, such as tumor metastases.
    Type: Grant
    Filed: February 12, 1997
    Date of Patent: July 23, 2002
    Assignees: Human Genome Sciences, Inc., Smithkline Beecham Corporation
    Inventors: Gregg A. Hastings, Mark D. Adams, Claire M. Fraser, Norman H. Lee, Ewen F. Kirkness, Judith A. Blake, Lisa M. Fitzgerald, Fred H. Drake, Maxine Gowan